Skip to main content

Are you Greenwich Rx - GLP Winner? Claim this listing to update your information and add verification.

Claim listing
503A Pharmacy
Verified listing

Verified

Greenwich Rx - GLP Winner

Connecticut, United States

No rating available

Fat Loss

Greenwich Rx is a 503A compounding pharmacy established in 2025 that compounds semaglutide, tirzepatide, and related medications. The pharmacy is not licensed in California and ships to patients working with various telehealth providers. Patient reviews report mixed experiences with shipping, product quality concerns, and questions about medication efficacy.

Peptides offered at Greenwich Rx - GLP Winner

2
Not sure which of these fit your goals? Use our research guides.

Provider Details

503A Compounding Pharmacy

Prescriptions are required. Compounds are prepared to order for individual patients and cannot be sold in bulk without a physician order.

Coverage

Country
United States
State
Connecticut
Telehealth
Not available
Regions Served
United States

Compliance

Verified Listing
Yes
Compliance Type
503A Compounding

Verification & FDA Records

Verified listing· · 503A Compounding Pharmacy

Report an error

Greenwich Rx - GLP Winner

Use this form to flag incorrect data, outdated information, or a misattributed finding. Our team reviews every report.

Related providers

Track this provider

Know when Greenwich Rx - GLP Winner changes.

Get an email when their verification status, reviews, or peptide list is updated.

Listed on PeptideBase badge

Add this badge to your website

Profile last updated

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

Free Guide

The Peptide Research Digest

Get our free provider vetting guide — plus weekly research briefings on peptide sourcing, COA verification, and clinical developments.

No spam.